Eger K - Search Results

1

Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons.

Eschke D, Brand A, Scheibler P, Hess S, Eger K, Allgaier C, Nieber K. Eschke D, et al. Among authors: eger k. Neurochem Int. 2001 Apr;38(5):391-8. doi: 10.1016/s0197-0186(00)00113-3. Neurochem Int. 2001. PMID: 11222919

2

7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.

Hess S, Müller CE, Frobenius W, Reith U, Klotz KN, Eger K. Hess S, et al. Among authors: eger k. J Med Chem. 2000 Nov 30;43(24):4636-46. doi: 10.1021/jm000967d. J Med Chem. 2000. PMID: 11101355

3

Synthesis and immunological activity of water-soluble thalidomide prodrugs.

Hess S, Akermann MA, Wnendt S, Zwingenberger K, Eger K. Hess S, et al. Among authors: eger k. Bioorg Med Chem. 2001 May;9(5):1279-91. doi: 10.1016/s0968-0896(00)00342-4. Bioorg Med Chem. 2001. PMID: 11377186

4

Rapid and sensitive LC separation of new impurities in trimethoprim.

Hess S, Akermann M, Ropte D, Eger K. Hess S, et al. Among authors: eger k. J Pharm Biomed Anal. 2001 Jun;25(3-4):531-8. doi: 10.1016/s0731-7085(00)00595-1. J Pharm Biomed Anal. 2001. PMID: 11377033

5

Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance.

Hess S, Teubert U, Ortwein J, Eger K. Hess S, et al. Among authors: eger k. Eur J Pharm Sci. 2001 Dec;14(4):301-11. doi: 10.1016/s0928-0987(01)00198-1. Eur J Pharm Sci. 2001. PMID: 11684404

6

Separation, analyses and syntheses of trimethoprim impurities.

Hess S, Dölker M, Haferburg D, Kertscher HP, Matysik FM, Ortwein J, Teubert U, Zimmermann W, Eger K. Hess S, et al. Among authors: eger k. Pharmazie. 2001 Apr;56(4):306-10. Pharmazie. 2001. PMID: 11338669

7

Aza analogues of thalidomide: synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro.

Gütschow M, Hecker T, Thiele A, Hauschildt S, Eger K. Gütschow M, et al. Among authors: eger k. Bioorg Med Chem. 2001 Apr;9(4):1059-65. doi: 10.1016/s0968-0896(00)00323-0. Bioorg Med Chem. 2001. PMID: 11354662

8

Inhibition of protein phosphatases by Michael adducts of ascorbic acid analogues with alpha,beta-unsaturated carbonyl compounds.

Witt UG, Schultz JE, Dölker M, Eger K. Witt UG, et al. Among authors: eger k. Bioorg Med Chem. 2000 Apr;8(4):807-13. doi: 10.1016/s0968-0896(00)00013-4. Bioorg Med Chem. 2000. PMID: 10819169

9

5'-Substituted thalidomide analogs as modulators of TNF-alpha.

Teubert U, Zwingenberger K, Wnendt S, Eger K. Teubert U, et al. Among authors: eger k. Arch Pharm (Weinheim). 1998 Jan;331(1):7-12. doi: 10.1002/(sici)1521-4184(199801)331:1<7::aid-ardp7>3.0.co;2-n. Arch Pharm (Weinheim). 1998. PMID: 9507696

10

Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.

Müller CE, Geis U, Grahner B, Lanzner W, Eger K. Müller CE, et al. Among authors: eger k. J Med Chem. 1996 Jun 21;39(13):2482-91. doi: 10.1021/jm960011w. J Med Chem. 1996. PMID: 8691445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters